Camras CB

Feldman R

Hedman

Hedman K

Hitchings R

Kampik A and the European Study Group

Kobelt G

Lichter PR

Odberg T

Orzalesi N

Stjernschantz J

Stjernschantz JW

 Despite treatment, glaucoma patients may still suffer vision loss because of inadequate control of intraocular pressure or late presentation. This article reviews the latest evidence supporting a reappraisal of first-line treatment in the management of glaucoma, including a review of latanoprost, recently approved for first-line treatment of glaucoma and ocular hypertension. </jats:p

Peter Phelan

Crossref

Hospital Medicine

Reappraising first-line treatment in glaucoma management

Reappraising first-line treatment in glaucoma management

Abstract

Similar works

Full text

Available Versions

Crossref